SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
THOR Analysis & Videos »
THOR: Bull or Bear?
FDA Calendar Updates: NeurogesX, Thoratec
THOR
|
|
|
+25.46%
in
121 days
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 288 entries as of 8/5/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, ANDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage cli...
|
Small-cap stock #5: Thoratec (THOR)
THOR
+9.08%
in
201 days
Filed under: Stocks to Buy, Best Stocks for 2009  Thoratec (NASDAQ: THOR), known for its ventricular assist devices (VADs) for patients suffering late-stage heart failure, recently bought Australia's HeartWare. Investors responded positively to this move because it brings new technology to Thoratec and expands the company's already significant market share.
<>THOR currently has 85% of the U.S. heart pump market and 65% of Europe's, and this new technology could ensure THOR stays on the top of this market for at least the next five to 10 years. The Thoratec-HeartWare partnership has the potentia...
|
5 small-cap stocks to buy now
THOR
+0.00%
in
1 day
(closed on 05/17/09)
Filed under: Stocks to Buy, Best Stocks for 2009  Small-cap stocks are a GREAT place to start if you're serious about rebuilding your wealth and securing your financial future.
But what makes small-cap stocks so spectacular? The bear market stripped analysts from small stocks -- hardly anyone is covering them anymore. This creates wonderful pricing anomalies and gives the individual investor a significant edge. <>In addition, earnings are a big no-show among the big blue chips this season. It's not just the Big 3 automakers -- it's Cisco (NASDAQ: CSCO) and Microsoft (NASDAQ: MSFT), too. Yesterday'...
|
FDA, Clinical Trial Calendar Updates: THOR, ALTH
THOR
|
|
|
-8.22%
in
107 days
(closed on 08/05/09)
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA for complete r...
|
Bullish on THOR ...
THOR
|
|
|
+2.01%
in
72 days
(closed on 04/20/09)
<> While the departure of Tom Daschle and concerns over rising unemployment and the global economic slowdown may hamper many of President Obama's plans for healthcare reform; there are several growth trends within the sector outlined below which are poised to benefit in 2009 and beyond. Follow any of the links below for more information on the new ETF Innovators indexes and exchange-traded fund ideas for the sector.
Global Health IT : The top five rated companies include Swiss telemedicine firm Card Guard (CDGUF) – a pro< />< />< />< /><>< />< />< />< /><><>< />< /><>< />< />< />< /><>...
|
A New Global Healthcare Composite Index
THOR
|
|
|
-12.39%
in
25 days
(closed on 02/07/09)
<> 
The accompanying table [click to enlarge] presents the top five rated companies with market caps of at least $100M from each of the eight new ETF Innovators healthcare indexes, including a database exceeding 500 companies worldwide. The Healthcare Composite Index is a dynamic, semi-active index with quarterly rebalancing which consists of the 40 top-rated companies on an equal weight basis from each of the eight global healthcare indexes listed below and represents an alternative strategy to existing health composite ETF...
|
A New Index of Health Product Innovators
THOR
|
|
|
-7.95%
in
8 days
(closed on 01/13/09)
<> 
The accompanying table includes statistics and all 23 companies in the ETF Innovators [ETFI] Global Health Innovators Index of companies with market caps over $250M which received FDA approval in the past 12 months for an original new drug product or medical device.
The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding all new formulations of existing drugs, generic drugs, and label extensions for existing products). Also, companies whi...
|
Stem Cell & Regenerative Medicine Stocks Surge in Past Month
THOR
|
|
|
+6.47%
in
15 days
(closed on 01/05/09)
<> 
The accompanying table [click to enlarge] includes the Top 10 Rated companies among a total of 64 and statistics for the ETF Innovators [ETFI] Cosmetic and Reconstructive Medicine [CRM] Index, which includes companies with market caps over $100M engaged in cosmetic medicine products, regenerative medicine + stem cells, orthopedic repair, joint replacements, and cardiovascular (heart + blood vessels) treatments.
The Top 10 Rated companies are dominated by those focusing on cardiovascular treatments...
|
Stock Ideas from ETF Innovators New Indexes
THOR
|
|
|
+2.27%
in
13 days
(closed on 12/20/08)
<> Below is a list of 14 stock opportunities from various ETF Innovators [ETFI] indexes, which includes a database of over 1,000 companies. The companies are chosen across a full spectrum of market cap and risk level from a variety of industry groups.
From the ETFI Highly Defensive PerformIdex , I believe Altria Group (MO) and Pfizer (PFE) are defensive dividend, value buys at current levels as each company currently pays a dividend of $1.28 per share annually – resulting in historically high dividend yields for bot<>< />< /><><><>< />< /><><><>< />< /><><>< />< /><><>< />< /><><>< />< /><><><><><><>< />< /><><><><>< />< />< />< />< />< />< />< />...
|
R&D Leads to Higher Returns for Top 20 Health Innovators
THOR
|
|
|
+46.76%
in
14 days
(closed on 12/07/08)
<> 
<> The accompanying table includes statistics and the top 20 rated companies in the ETF Innovators [ETFI] Global Health Innovators Index of companies with market caps over $250M which received FDA approval in the trailing 12-month period for either an original new drug product or medical device. The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding reformulations of existing drugs, generic drugs, and label extensions for exist...
|
ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?
THOR
|
|
|
-12.62%
in
11 days
(closed on 11/23/08)
<> 
<> The accompanying table includes statistics and the top five rated companies in the ETFI Global Health Innovators Index of companies with market caps over $100M which received FDA approval in the trailing 12-month period for either an original new drug or medical device product. The index includes companies which get approvals for drugs or biological agents classified as new chemical entities (i.e. excluding reformulations of existing drugs, generic drugs, and label extensions for existing produc...
|
Bookkeeping: Adding to Thoratec (THOR)
THOR
|
|
|
+13.86%
in
455 days
I just wanted to point this out, to showcase how we all have the same experiences in this market. I had pointed out Thoratec (THOR) about a month ago, and had waited patiently for some kind of serious pullback - it never came. Finally yesterday I threw in the towel and initiated a beginner stake (I capitulated, tired of waiting for it). Now today, it has the pullback, down 7%+ :)
Since it has fallen nicely to the 20 day moving average and is in the 1 space in the market that is "relatively" sensible to invest in on fundamentals, and is being rewarded, I will incrementally buy more here in...
|
Bookkeeping: Initating Position in Thoratec (THOR) and Adding to Other Healthcare
THOR
|
|
|
+1.83%
in
24 hours
(closed on 09/04/08)
I continue to watch my limit order for Thoratec (THOR) down in the $23s continue to mock me on a daily basis, so I'm going to "capitulate" and get at least a starter position going in this name here in the mid $27s. I wrote a detailed piece on the name in early August [Aug 4: One for the Radar - Thoratec] so I won't rehash it. It is hard to find charts like this so I'm going to jump on board here and hope for a pullback in stock price to increase the exposure.
For now we start with a 1.1% stake, and I'd love to see this fall back to the $23s but I've been saying that to myself for nearly 3...
|
People Bullish on THOR
People Bearish on THOR
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on THOR |
Be the first to start a discussion and earn 2 points.
More Resources
|
About Thoratec Corp.
- Answers.com
